Growth-hormone pathway research peptides support studies of pulsatile hormone release through two distinct receptor mechanisms. Ipamorelin acts on the ghrelin receptor with high selectivity; CJC-1295 (no DAC) acts on the GHRH receptor. The two are frequently studied together in combined-pathway protocols.
Standing orders and institutional billing are handled directly by our team.
